Bernhard Ryffel
Université d'Orléans · 767 works · 52,296 citations · h-index 107
Top works
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- Interferon gamma receptor deficient mice are resistant to endotoxic shock.
- Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
- Interleukin-17 is a negative regulator of established allergic asthma
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
- Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice
- Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling.
- Cyclosporin receptors on human lymphocytes.
- Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- Histopathology of cyclosporine nephrotoxicity.
- IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice
- Cyclosporin receptor on mouse lymphocytes.
- NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
- Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice
- The side-effects of ciclosporine-A and tacrolimus.